209 related articles for article (PubMed ID: 21409237)
1. Gadolinium-doped LipoCEST agents: a potential novel class of dual 1H-MRI probes.
Terreno E; Boffa C; Menchise V; Fedeli F; Carrera C; Castelli DD; Digilio G; Aime S
Chem Commun (Camb); 2011 Apr; 47(16):4667-9. PubMed ID: 21409237
[TBL] [Abstract][Full Text] [Related]
2. From spherical to osmotically shrunken paramagnetic liposomes: an improved generation of LIPOCEST MRI agents with highly shifted water protons.
Terreno E; Cabella C; Carrera C; Delli Castelli D; Mazzon R; Rollet S; Stancanello J; Visigalli M; Aime S
Angew Chem Int Ed Engl; 2007; 46(6):966-8. PubMed ID: 17167807
[No Abstract] [Full Text] [Related]
3. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.
Aime S; Castelli DD; Crich SG; Gianolio E; Terreno E
Acc Chem Res; 2009 Jul; 42(7):822-31. PubMed ID: 19534516
[TBL] [Abstract][Full Text] [Related]
4. Highly shifted LIPOCEST agents based on the encapsulation of neutral polynuclear paramagnetic shift reagents.
Terreno E; Barge A; Beltrami L; Cravotto G; Castelli DD; Fedeli F; Jebasingh B; Aime S
Chem Commun (Camb); 2008 Feb; (5):600-2. PubMed ID: 18209802
[TBL] [Abstract][Full Text] [Related]
5. Osmotically shrunken LIPOCEST agents: an innovative class of magnetic resonance imaging contrast media based on chemical exchange saturation transfer.
Terreno E; Delli Castelli D; Violante E; Sanders HM; Sommerdijk NA; Aime S
Chemistry; 2009; 15(6):1440-8. PubMed ID: 19115311
[TBL] [Abstract][Full Text] [Related]
6. A benzene-core trinuclear GdIII complex: towards the optimization of relaxivity for MRI contrast agent applications at high magnetic field.
Livramento JB; Helm L; Sour A; O'Neil C; Merbach AE; Tóth E
Dalton Trans; 2008 Mar; (9):1195-202. PubMed ID: 18283380
[TBL] [Abstract][Full Text] [Related]
7. Supramolecular protamine/Gd-loaded liposomes adducts as relaxometric protease responsive probes.
Figueiredo S; Moreira JN; Geraldes CF; Aime S; Terreno E
Bioorg Med Chem; 2011 Feb; 19(3):1131-5. PubMed ID: 20719523
[TBL] [Abstract][Full Text] [Related]
8. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon.
Hanaoka K; Kikuchi K; Terai T; Komatsu T; Nagano T
Chemistry; 2008; 14(3):987-95. PubMed ID: 17992679
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and characterization of novel natural product-Gd(III) MRI contrast agent conjugates.
Efthimiadou EK; Katsarou ME; Fardis M; Zikos C; Pitsinos EN; Kazantzis A; Leondiadis L; Sagnou M; Vourloumis D
Bioorg Med Chem Lett; 2008 Dec; 18(23):6058-61. PubMed ID: 18938075
[TBL] [Abstract][Full Text] [Related]
10. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents.
Laus S; Ruloff R; Tóth E; Merbach AE
Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682
[TBL] [Abstract][Full Text] [Related]
11. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents.
Caravan P
Chem Soc Rev; 2006 Jun; 35(6):512-23. PubMed ID: 16729145
[TBL] [Abstract][Full Text] [Related]
12. Optimization of gadolinium-based MRI contrast agents for high magnetic-field applications.
Helm L
Future Med Chem; 2010 Mar; 2(3):385-96. PubMed ID: 21426173
[TBL] [Abstract][Full Text] [Related]
13. Gadolinium(III) 1,2-hydroxypyridonate-based complexes: toward MRI contrast agents of high relaxivity.
Xu J; Churchill DG; Botta M; Raymond KN
Inorg Chem; 2004 Sep; 43(18):5492-4. PubMed ID: 15332797
[TBL] [Abstract][Full Text] [Related]
14. Structural and relaxometric characterization of peptide aggregates containing gadolinium complexes as potential selective contrast agents in MRI.
Vaccaro M; Mangiapia G; Paduano L; Gianolio E; Accardo A; Tesauro D; Morelli G
Chemphyschem; 2007 Dec; 8(17):2526-38. PubMed ID: 17960748
[TBL] [Abstract][Full Text] [Related]
15. Efficient relaxivity enhancement in dendritic gadolinium complexes: effective motional coupling in medium molecular weight conjugates.
Fulton DA; O'Halloran M; Parker D; Senanayake K; Botta M; Aime S
Chem Commun (Camb); 2005 Jan; (4):474-6. PubMed ID: 15654374
[TBL] [Abstract][Full Text] [Related]
16. Highly sensitive MRI chemical exchange saturation transfer agents using liposomes.
Aime S; Delli Castelli D; Terreno E
Angew Chem Int Ed Engl; 2005 Aug; 44(34):5513-5. PubMed ID: 16052647
[No Abstract] [Full Text] [Related]
17. Orthogonal synthesis of a heterodimeric ligand for the development of the Gd(III)-Ga(III) ditopic complex as a potential pH-sensitive MRI/PET probe.
Vologdin N; Rolla GA; Botta M; Tei L
Org Biomol Chem; 2013 Feb; 11(10):1683-90. PubMed ID: 23360969
[TBL] [Abstract][Full Text] [Related]
18. Gd(DO3A-N-alpha-aminopropionate): a versatile and easily available synthon with optimized water exchange for the synthesis of high relaxivity, targeted MRI contrast agents.
Ferreira MF; Martins AF; Martins JA; Ferreira PM; Tóth E; Geraldes CF
Chem Commun (Camb); 2009 Nov; (42):6475-7. PubMed ID: 19841814
[TBL] [Abstract][Full Text] [Related]
19. Entrapment of a neutral Tm(III)-based complex with two inner-sphere coordinated water molecules into PEG-stabilized vesicles: towards an alternative strategy to develop high-performance LipoCEST contrast agents for MR imaging.
Chahid B; Vander Elst L; Flament J; Boumezbeur F; Medina C; Port M; Muller RN; Lesieur S
Contrast Media Mol Imaging; 2014; 9(6):391-9. PubMed ID: 24760773
[TBL] [Abstract][Full Text] [Related]
20. In vitro characterization of the Gd complex of [2,6-pyridinediylbis(methylene nitrilo)] tetraacetic acid (PMN-tetraacetic acid) and of its Eu analogue, suitable bimodal contrast agents for MRI and optical imaging.
Laurent S; Vander Elst L; Wautier M; Galaup C; Muller RN; Picard C
Bioorg Med Chem Lett; 2007 Nov; 17(22):6230-3. PubMed ID: 17889530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
